Mycobacterium tuberculosis (Mtb) is spread via aerosolized droplets and makes 'first contact' with a new host in the alveolar space, an interaction largely inaccessible to experimental observation. We establish a lung-on-chip as an infection model for early tuberculosis, where time-lapse imaging at an air-liquid interface reveals the dynamics of early host-Mtb interactions 15 with a spatiotemporal resolution unattainable in animal models. Pulmonary surfactant mediates a non-growing Mtb population in both alveolar epithelial cells (AECs) and macrophages, although AECs are more permissive to Mtb growth. Defective surfactant production leads to uncontrolled rapid Mtb growth in both cell types which can be partially rescued by formulations containing
Abstract: Mycobacterium tuberculosis (Mtb) is spread via aerosolized droplets and makes 'first contact' with a new host in the alveolar space, an interaction largely inaccessible to experimental observation. We establish a lung-on-chip as an infection model for early tuberculosis, where time-lapse imaging at an air-liquid interface reveals the dynamics of early host-Mtb interactions 15 with a spatiotemporal resolution unattainable in animal models. Pulmonary surfactant mediates a non-growing Mtb population in both alveolar epithelial cells (AECs) and macrophages, although AECs are more permissive to Mtb growth. Defective surfactant production leads to uncontrolled rapid Mtb growth in both cell types which can be partially rescued by formulations containing surfactant phospholipids. AECs thus have both host-protective and pathogen-permissive roles during first contact, which may explain the full spectrum of human disease and inform new therapeutic interventions.
One Sentence Summary: Live imaging in a lung-on-chip model for early tuberculosis reveals pulmonary surfactant significantly attenuates bacterial growth 5 Main Text:
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is characterized by extensive host-pathogen interactions that result in diverse outcomes: although the infectious dose can be as low as one, only 5-10% of individuals exposed to TB develop an active infection (1). The 10 infection is also strongly influenced by host physiology: only the smallest aerosol droplets containing 1-2 bacilli can be successfully delivered to the site of infection in the alveolar space (2, 3), whose vast surface area is lined with pulmonary surfactant and is only sparsely populated with alveolar macrophages (4) . The 'first contact' with a naïve host is therefore by default a single-cell interaction, where heterogeneous outcomes may determine the future course of 15 infection. Potential sources of heterogeneity include cell-to-cell differences in macrophage populations (5, 6) , infection of alveolar epithelial cells (7) , and the action of pulmonary surfactant (8) (9) (10) . These factors have not been characterized completely within the native setting in the lung, primarily because experiments in animal models (11) cannot provide information about the dynamics of host-Mtb interactions at this stage with sufficient spatiotemporal 20 resolution (12, 13) . The most commonly-used model, in vitro infection of macrophages with Mtb (14) , does provide excellent spatiotemporal resolution but does not reflect the complexity of the tissue environment in vivo.
Bottom-up organ-on-chip systems made of polydimethylsiloxane (PDMS) or biocompatible hydrogels recreate host physiology where tissue-level complexity (15, 16) is incorporated in a modular fashion i.e. the number of cellular components, their identity, and environmental 5 complexity can be tailored to mimic key aspects of the relevant physiology e.g., an air-liquid interface (ALI) in a lung-on-a-chip (LoC) (15, 17) . These approaches have emerged as crucial tools for the replacement of animal models in drug development, toxicity testing, and for personalised medicine applications (18, 19) . Thus far, a less-explored line of enquiry has been to use them as tools or platforms to study host-pathogen interactions (20) , where they can occupy 10 the middle ground between simple in vitro experiments and an animal model (21) .
We therefore establish an LoC model for the early stages of TB infection that in conjunction with live-cell time-lapse microscopy, allows us to dissect the infection dynamics for both AECs and macrophages as independent sites of first contact, and study crosstalk between them mediated by pulmonary surfactant. 15 
Lung-on-a-chip model of tuberculosis
We established a lung-on-chip infection model suitable for time-lapse imaging of early events in tuberculosis ( Fig. 1A) . Freshly isolated mouse alveolar epithelial cells (AECs) comprise a mix of type I cells ( Fig. S1A ) and type II cells that produce high surfactant (HS) levels ( Fig. S1B ). Fig. 2J, L) . In a substantial fraction of infected cells, total fluorescence intensity of the intracellular bacteria increases very slowly (growth rate < 1/168 h -1 ) or decreases over time. In the absence of a validated live/dead marker, we define these infected cells as a "non-growing fraction" (NGF):
Comparison of the distributions of bacterial growth rates within individual host cells under HS conditions reveals that intracellular growth is significantly faster in AECs than in macrophages Table S2 ). This dynamic is however altered in the ΔRD1-like 5'Tn::pe35 strain deficient in Type VII ESX-1 secretion (22) . A functional ESX-1 system has been shown to be required for Mtb to escape into the cytosol (23) , and its secretion is also upregulated during AEC infection (24) . The absence of surfactant does not lead to rapid growth in both AECs (Fig. 3E , F) and macrophages ( Fig. 3G, H) , although AECs are more permissive 5 than macrophages in both HS and LS conditions ( Fig. S4C, D) . When compared to WT, growth is particularly attenuated in both cell types in LS conditions ( Fig. S5B, D) . ESX-1 secretion is therefore necessary for rapid growth in the absence of surfactant, which also suggests that surfactant itself, either directly or indirectly, reduces ESX-1 levels on the Mtb capsule. This is in line with a recent study reporting that detergents remove EsxA on the Mtb capsule (25) . Slower 10 growth in AECs might also explain the delayed dissemination of this strain to the spleen (22) .
A more subtle mutant is the ΔpcaA knockout, which has an altered mycolic acid composition in the capsule (26) and is transiently attenuated only during the early stages of infection in the mouse model (27) . In many aspects this strain behaves similar to WT; growth is significantly attenuated in AECs and macrophages by surfactant ( Fig. 3I -L), AECs are more permissive than 15 macrophages under HS conditions, but the differences are not significant in LS conditions ( Fig.   S4E , F). The ΔpcaA strain however is also unable to grow as rapidly as WT in LS conditions in both AECs and macrophages ( Fig. S5B, D) . Recent studies have reported up-regulation of the PcaA enzyme and other mycolic acid biosynthesis pathways in early infection in alveolar macrophages in vivo, but not in in vitro macrophage infections (28, 29) . Our results indicate that 20 LoC model successfully recapitulates the former but not the latter phenotype, an important validation of the model. Taken together, these results strongly suggest that pulmonary surfactant limits Mtb growth in both cell types.
LoC model in HS conditions accurately reflects in vivo attenuation
The differences between both mutant strains relative to WT are subtle; the 5'Tn::pe35 strain has a fourfold higher NGF fraction in AECs (Fig. 3F ), and the ΔpcaA NGF fraction in macrophages 5 is ~20% higher (Fig. 3K ). The median values of growth rate are not significantly different ( Fig.   S5 A, C), however small differences in the shapes of the distribution (reflected in the spread of the 1-99 percentile interval in S5 A, C) are rapidly amplified by exponential growth, and can generate significant differences in total bacterial numbers, the typical metric measured in animal experiments. To illustrate this, we simulated a low-dose animal infection (infectious dose=50 at 10 1 dpi), assumed each microcolony grew only in macrophages and assigned each microcolony a growth rate randomly chosen from the population distributions. Simulations show bacterial numbers of the WT and ΔpcaA strains at 2 days post infection ( Fig. 4A) , are already significantly different (n=100, p=0.018). Over the first week of infection, the relative attenuation of the ΔpcaA strain relative to WT monotonically increases ( Fig. 4B ). Interestingly, the attenuation (and 15 heterogeneity) predicted by this simple model is in good agreement with experimental data at 7 days post infection (and explain the plateauing of this attenuation); whereas the predicted attenuation under LS conditions is more severe than reported (27) . A similar trend is evident for the 5'Tn::pe35 strain, whose attenuation with respect to WT in the mouse model (22) is better predicted by the HS dataset than the LS dataset ( Fig. S6A, B ). An even starker example of 20 attenuation is the Δicl1Δicl2 knockout that is severely attenuated in vivo (30) . Even at 6 days post infection ( Fig. S7A -C) of a LS LoC infected with a high multiplicity of infection, there is little or no growth in both AECs and macrophages; many macrophages contain numerous single Mtb bacteria. This lack of growth also rules out the possibility that Mtb grow only extracellularly in the LoC without infecting host cells. These results show that the LoC infection model meets the benchmarks set by data from in vivo experiments, the physiology of which is accurately 5 represented by HS conditions.
Hydrophobic surfactant components interact directly with Mtb
Lastly, we tested if Curosurf TM , a pulmonary surfactant replacement formulation composed of phospholipids (39% w/v dipalmitoylphospatidylcholine (DPPC)) and the hydrophobic proteins SP-B and SP-C, could rescue the phenotype observed in LS LoCs. Treatment with a dilute 10 solution of Curosurf either added to the alveolar face for a short period before infection with WT bacteria ('Chiptreat') or allowed to interact with resuspended Mtb cultures prior to the infection of an untreated LS LoC ('Mtbtreat') attenuated growth and generated an NGF ( Fig. 5A , Table   S2 ). Curosurf treatment of a single-cell Mtb suspension did not affect Mtb growth in vitro ( Fig.   S8 ). 15 One hypothesis is that the attenuation upon infection is due to the direct interaction of surfactant interactions mediated by surfactant. When surfactant is reduced, WT Mtb grows more rapidly than in vitro axenic culture; a trait that is shared to a lesser extent by mutants attenuated for known virulence factors. In the presence of surfactant, a significant fraction of bacteria do not grow as judged by fluorescent expression levels. It is likely that a majority of these are indeed sterilized, however we do not have definitive proof of this. Nevertheless, they are not active 20 participants in these early stages of infection. On the contrary, AECs are active participants, not only through the production of pulmonary surfactant already discussed but also as a site of first contact despite being surrounded by macrophages. It is likely that the current LoC model and method of Mtb inoculation exaggerate the incidence of AEC infection; however, this gives us an opportunity to study both AEC and macrophage infections in co-culture at the ALI. The significant differences in outcome between AECs and macrophages in the presence of surfactant suggest that even were AEC infections to occur far more infrequently in vivo, it would probably 5 lead to a more aggressive infection.
The exact mechanisms of surfactant-mediated attenuation remain to be elucidated, but this work demonstrates a direct physical interaction that is a two-way street: Mtb surface lipids are actively removed while surfactant lipids coat the bacterial surface. These interactions are independent of the action of hydrophilic SP-A and SP-D proteins that have previously shown to interact with 10 Mtb surface lipids (39) (40) (41) , and enzymes shown to modify the Mtb capsule (9, 10) , none of which are components of Curosurf. These components have been shown to be potent adjuvants for intranasal influenza vaccines (42) , suggesting the possibility that pulmonary surfactant could be harnessed to generate improved therapeutics and host-directed therapies against the spread of TB. 
Materials and Methods

Cell culture
Primary C57BL/6 alveolar epithelial cells (AECs) and lung microvascular endothelial cells ('endothelial') were obtained from a commercial supplier (Cell Biologics. USA). Each vial of AECs consisted of a mix of Type I and Type II AECs, which was verified both by 5 immunostaining (Fig. S1A-C, Fig, S1F ). Both cell types were cultured in vitro in the recommended medium (complete medium) supplied by Cell Biologics in 5% CO 2 at 37°C that consisted of a base medium and supplements. In the case of lung-on-chip (LoCs) reconstituted in high surfactant (HS) conditions, AECs were seeded directly on-chip (see below), without prior in vitro culture. Low surfactant (LS) AECs are typically passaged 6-11 times before use. 10 Bone marrow isolation and culture staining. Confocal images were obtained on a Leica SP8 inverted microscope. 25 Bacterial culture
All bacterial strains were derived from Mycobacterium tuberculosis Erdman and cultured at 37°C. Liquid medium is Middlebrook 7H9 (Difco) supplemented with 0.5% albumin, 0.2% glucose, 0.085% NaCl, 0.5% glycerol, and 0.02% Tyloxapol. Solid medium is Middlebrook 7H11 (Difco) supplemented with 10% OADC enrichment (Becton Dickinson) and 0.5% glycerol. Aliquots were stored in 15% glycerol at -80°C and used once to avoid loss of virulence.
All strains were modified to allow constitutive expression of the fluorescent protein tdTomato under the control of the native promoter at the attB site. WT refers to the Erdman strain 5 expressing tdTomato. The 5'Tn::pe35 strains was generated using transposon mutagenesis (22) and the ΔpcaA strain is a kind gift from the lab of Prof Michael Glickman(26, 27) .
Murine LoC model
Lung-chips made of polydimethylsiloxane (PDMS) were obtained from Emulate (Boston, 10 MA). ECM coating was performed as per manufacturer instructions. Chips were activated using ER-1 solution (Emulate) dissolved in ER-2 solution at 0.5 mg/ml (Emulate) and exposed for 20
minutes under UV light. The chip was then rinsed with coating solution and exposed again to UV light for a further 20 minutes. Chips were then washed thoroughly with PBS before incubating with an ECM solution of 150 μg/ml bovine collagen type I (Atelo) and 30 μg/ml 15 fibronectin from human plasma (Sigma-Aldrich) in PBS buffered with 15 mM HEPES solution (Gibco) for 1-2 hours at 37°C. If not used directly, coated chips were stored at 4C, and preactivated before use by incubation for 30 minutes with the same ECM solution at 37C.
Endothelial cells cultured overnight at 37°C, 5% CO 2 in T-75 cell culture flasks, detached with 0.05% Trypsin and concentrated to 5-10 million cells/ml were seeded on the bottom face of the 20 PDMS membrane. The chip is then incubated for a short period at 37°C to allow the endothelial cells to spread and is subsequently seeded with AECs. Freshly isolated AECs are seeded directly from cryopreserved vials received from the supplier. LS LoCs are seeded from cells cultured overnight at 37°C, 5% CO 2 , in both cases at a concentration of 1-2 million cells/ml. The chip is incubated overnight with complete epithelial and endothelial media in the epithelial and 25 endothelial channel respectively under static conditions. The next day, the chip is washed and a reduced medium for the air-liquid interface (ALI) is flowed through the vascular channel using syringe pumps (Aladdin-220, Word Precision Instruments) at 60 μl/hour in a manner described in (43) . The components of ALI media are also described in (43) , however we used an increased FBS concentration of 5%.
The (Table S1 ). The chip is incubated for 2-3 hours at 37°C, 5 5% CO 2 to allow Mtb infection of cells on the epithelial face. At the end of this period, the solution on the epithelial face is withdrawn (in some cases, a portion of this is retained and plated for cfu to estimate the proportion of bacteria than remain on the chip (labelled 'postinf' in Table   S1 ). The epithelial face is returned to ALI, and the inlets of the infected chip are sealed with solid pins as a safety precaution for microscopy imaging in the BSL-3 facility. 10 
Time-lapse microscopy of the Mtb infected LoC
The LoC in the stage top incubator is placed on the stage of a widefield Nikon Ti-2 microscope, and the stage top incubator is connected to a gas mixer (Okolab) to ensure 5% CO 2 throughout the imaging period. Flow of media through the vascular channel is maintained 15 throughout this period through the use of a syringe pump. The chip is imaged using a long working distance 20x phase contrast objective (NA=0.75, Ph2 Nikon) at either 1.5 hour or 2hour imaging intervals. The epithelial face of the chip (where the refractive index differences are highest) is maintained in focus using the Nikon Perfect Focus System over this period. At each timepoint, a Z-stack of 9-10 images, with an axial spacing of 10 μm is taken series for a series of 20 fields of view along the length of the chip. This is to account for the dynamic 3D movement of macrophages between both faces, as well as drift in focus over time. Data is first visualized using ImageJ where macrophage and AEC infection from each field of view is visually curated, considering the co-localization of fluorescent signals over time.
Smaller stacks of 1-2 microcolonies are assembled. Custom-written software in MATLAB is used to measure the total fluorescence intensity of each microcolony and uses the nestedSortStruct algorithm for MATLAB written by the Hughey lab (Jake Hughey (2020). 10 nestedSortStruct (https://www.github.com/hugheylab/nestedSortStruct), GitHub). Briefly, at each timepoint, the Z-stack with the highest intensity in the fluorescence channel was identified, this image is then segmented to identify the microcolony, and total fluorescence measured by summing the intensity of all the pixels in this region, after subtracting a value for each pixel that represented the average background fluorescence in this channel. We choose the total 15 fluorescence intensity because it accounts for both bacterial growth and dilution of the fluorescent protein (which is low in a slow-growing bacterium like Mtb). We are unable to measure the volume of the microcolony accurately due to the choose to very poor axial resolution using widefield imaging with refractive index differences at ALI, therefore we obtain this value from only the Z stack with the highest intensity. Statistical analysis is performed using 20 Origin 9.2 (OriginLabs). P-values are calculated using a Kruskal-Wallis one-way ANOVA test, with the null hypothesis that the medians of each population are equal.
Simulations of in vivo infections
Growth rate datasets for WT, 5'Tn::pe35, and ΔpcaA strains in HS and LS conditions were 25 fitted with a non-parametric Kernel Smoothed distribution. We simulated a low-dose aerosol infection of 50 bacteria in the alveolar space of n=100 or n=100 mice, and conservatively assumed that every bacterium interacted with a macrophage upon first contact, as we do not have a reliable estimate for the frequency of AEC infection in vivo (although it is likely to be low).
Each bacterium was assigned a growth rate picked at random from the Kernel Smoothed distributions and assumed to grow exponentially with these growth rates to generate a microcolony. The total bacterial numbers in each mouse at 2, 3, 5, and 7 days post infection were obtained by summing the bacterial counts from each microcolony for each mouse. Total bacterial numbers for n=100 mice of WT and ΔpcaA 5'Tn::pe35 are shown in Fig. 4A and Fig. S6A   5 respectively. To compare relative attenuation of the ΔpcaA strains.
Curosurf treatment of LS LoCs
Curosurf (Chiesi Pharmaceuticals) was purchased and used as a 1% solution in epithelial media for all experiments. In the case where Curosurf was added to a LS LoC, a 1% solution was 10 introduced to the epithelial face after the macrophages were added but before ALI was introduced for 2 minutes, and then removed. The following morning, this procedure was repeated just prior to the addition of the single-cell suspension of Mtb in the manner described above.
Alternatively, 1ml of Mtb in exponential phase in 7H9 media was centrifuged at 5000g for 5 minutes and resuspended in 1ml of 1% cell culture media and incubated for 10-15 mins at room 15 temperature. This solution was then centrifuged again at 5000g for 5 minutes and a single-cell Mtb suspension was generated as described above. Fluorescent labelling of surfactant was achieved by adding TopFluor phosphatidylcholine (10% v/v, Avanti Polar Lipids) to Curosurf before dilution in cell culture media. 20 Total free lipid extraction and thin-liquid chromotgraphy (TLC)
10ml Mtb cultures were grown till stationary phase in 7H9 with 10 μC i of 14 C propionate added during exponential phase. Total free lipid extraction from bacterial pellet, supernatant, and the supernatant from bacteria pre-treated with a 3% Curosurf solution for 15 mins at 37C were extracted as described (44) . Extracted free lipids were air-dried, resuspended in 2:1 v/v solution 25 of cholorform:methanol and aliquots were spotted on 5 x 10 cm TLC silica gel 60 F 254 (Merck).
Running solvent was 90:10:1 chloroform:ethanol:water and the developed TLC plate was exposed to an Amersham Hyperfilm ECl (GE Healthcare) for phosphorescence imaging and visualised with a Typhoon scanner (GE Healthsciences). Intensities of the bands observed was quantified using ImageJ.
Bibliography
